Esperion Therapeutics
ESPR
#6744
Rank
โ‚น40.49 B
Marketcap
โ‚น188.23
Share price
-8.23%
Change (1 day)
138.15%
Change (1 year)

Esperion Therapeutics (ESPR) - P/B ratio

P/B ratio as of November 2024 : -1.39

According to Esperion Therapeutics's latest financial reports the company has a price-to-book ratio of 1.72714.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Esperion Therapeutics - P/B ratio (from 2013 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-31-0.7473-47.29%
2022-12-31-1.42-8.3%
2021-12-31-1.55-77.94%
2020-12-31-7.01-108.53%
2019-12-3182.2426.99%
2018-12-3115.6121.25%
2017-12-317.05470.68%
2016-12-311.24-29.21%
2015-12-311.74-71.67%
2014-12-316.16116.53%
2013-12-312.84
2012-12-31N/A
2003-12-31N/A
2002-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
10.4-846.31%๐Ÿ‡บ๐Ÿ‡ธ USA
2.35-268.37%๐Ÿ‡บ๐Ÿ‡ธ USA
1.64-217.37%๐Ÿ‡บ๐Ÿ‡ธ USA
3.08-320.72%๐Ÿ‡บ๐Ÿ‡ธ USA
17.3-1,343.18%๐Ÿ‡บ๐Ÿ‡ธ USA
1.81-229.80%๐Ÿ‡บ๐Ÿ‡ธ USA